CRON

CRON

USD

Cronos Group Inc. Common Share

$2.480+0.030 (1.224%)

Reaalajas hind

Healthcare
Drug Manufacturers - Specialty & Generic
Kanada

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$2.450

Kõrge

$2.500

Madal

$2.425

Maht

1.24M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

949.6M

Tööstusharu

Drug Manufacturers - Specialty & Generic

Riik

Canada

Kauplemisstatistika

Keskmine maht

2.79M

Börs

NGM

Valuuta

USD

52 nädala vahemik

Madal $1.6Praegune $2.480Kõrge $3.16

Seotud uudised

CNBC

'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance

Cannabis stocks could rally on hopes for new hemp regulations and Trump's possible softer stance on marijuana, fueling investor optimism across the industry.

Vaata rohkem
'Trump effect' raises hopes for cannabis rally as investors bet on federal reforms, softer marijuana stance
GlobeNewswire

Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season

TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos"), an innovative global cannabinoid company, announced today that it is welcoming back its limited-edition Caramel Green

Vaata rohkem
Cronos Brings Back Popular, Limited-Edition Spinach® Green Apple-Flavored Products for the Fall Season
GlobeNewswire

Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025

TORONTO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") will hold its 2025 third quarter earnings conference call on Thursday, November 6, 2025 at 8:30 a.m. ET.

Vaata rohkem
Cronos Group Inc. to Hold 2025 Third Quarter Earnings Conference Call on November 6, 2025

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.